ITGR

Thermo Fisher Scientific (TMO) reported quarterly earnings of $6.68 per share, beating consensus estimates of $6.4 and surpassing revenue expectations at $12.14 billion. The company has outperformed the market by 17.3% year-to-date and maintains a Zacks Rank #2 (Buy) rating with favorable estimate revision trends. Integer Holdings (ITGR), another medical device company, is expected to report declining earnings and revenues in its upcoming quarter.

Integer Holdings Corporation (ITGR) is drawing attention from options traders due to high implied volatility in its Dec. 18, 2026 $65 Put options, suggesting market expectations for significant price movement. The company holds a Zacks Rank #3 (Hold) rating in the Medical-Instruments industry, with analyst consensus estimates remaining relatively stable around $1.65-$1.66 per share for the current quarter.

Halper Sadeh LLC, an investor rights law firm, is investigating four companies for potential securities law violations and breaches of fiduciary duties related to their proposed transactions. The firm is examining whether shareholders are receiving fair consideration and whether insider benefits may be prioritized over ordinary shareholder interests.

In a comparison of two medical instruments stocks, Globus Medical (GMED) emerges as the superior value option over Integer (ITGR). GMED holds a Zacks Rank of #1 (Strong Buy) with improving earnings outlook, while ITGR has a Zacks Rank of #3 (Hold). GMED also demonstrates better valuation metrics with a forward P/E of 15.18 versus ITGR's 20.74, and a PEG ratio of 1.22 compared to ITGR's 2.40, earning GMED a Value grade of B versus ITGR's C.